EFFICACY, SAFETY, AND TOLERABILITY OF SELADELPAR IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS DUE TO PRIMARY BILIARY CHOLANGITIS (PBC); A POOLED ANALYSIS OF PHASE 2 AND PHASE 3 STUDIES Stuart C. Gordon , Palak Trivedi , Christopher L. Bowlus , Michael Galambos , Aparna Goel , Aliya Gulamhusein , Cynthia Levy , Guy Neff , Carmen M. Stanca , Douglas Thorburn , Bruce R. Bacon , Brian B. Borg , Yvonne Doerffel , Lisa Forman , Bradley Freilich , Liliana Gheorghe , Maria Sarai Gonzalez-Huezo , Stephen A. Harrison , Jonathan C. Huang , Sook-Hayng Jeong , Seung-Up Kim , John Lake , Joseph Odin , Won Young Tak , Hillel Tobias , John M. Vierling , Ke Yang , Alexandra Steinberg , Yun-Jung Choi , Charles A. Mcwherter , Marlyn J. Mayo JOURNAL OF HEPATOLOGY(2022)
关键词
liver cirrhosis, primary biliary cholangitis, compensated liver cirrhosis due, seladelpar
AI 理解论文
溯源树
样例